生物标志物 生物标志物
Fuqiang Gao1, Joel Ramirez2,3, Melissa F Holmes1
1Dr. Sandra Black Centre for Brain Resilience and Recovery, Sunnybrook Research Institute, Toronto, ON, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
在阿尔茨海默病 (AD) 中,周心室白质过强度 (pWMH) 与深髓静脉 (DMV) 问题有关. 这项研究表明,DMV静脉病变导致pWMH,表明静脉功能不充分导致慢性胀.
科学领域:
- 神经学 神经学
- 神经成像是一种神经成像.
- 病理学 病理学 病理学
背景情况:
- 周心室白质过强度 (pWMH) 在阿尔茨海默病 (AD) 中很常见,通常归因于缺血或脱髓化.
- 深髓静脉 (DMVs) 静脉病变,特别是闭塞性原病,越来越多地与pWMH发展有关.
- 静脉静止和淋巴系统功能障碍可能导致细胞外液的过度积累,导致慢性.
研究的目的:
- 为了研究在阿兹海默症患者的汇合pWMH和DMV之间的体内关联.
- 确定放射学和病理学证据,支持DMV静脉病变作为pWMH和相关的原因.
- 为了验证,将成像发现与病理学数据相关联.
主要方法:
- 包括88名AD患者和33名对照患者,在T2/FLAIRMRI上与pWMH相交.
- 定义了DMV并测量了它们与pWMH的空间关系.
- 评估了的放射性迹象,包括紧的白质道的节省和随时间变化的动态pWMH.
- 量化周血管空间和缺口,有13个成像病理相关性用于验证.
主要成果:
- 同流的pWMH与已识别的DMV有显著的共同位置.
- 在pWMH数量和DMV数量之间发现了强烈的关联.
- 病理学分析显示,大和小静脉中的静脉原酶是pWMH的重要预测因子.
结论:
- 在阿尔茨海默氏症患者中,流动的pWMH与可视化的DMV密切相关,这表明由于原病引起的静脉功能不充分.
- 在体内证据支持慢性,由紧的纤维管节省和可逆的pWMH进展表明.
- 研究结果表明,DMV静脉缺陷是pWMH的主要原因,导致血管性胀和细胞外液体积累.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511